How a cheap antidepressant emerged as a promising Covid-19 treatment
web.archive.org
Most Covid-19 drug treatments that have been included in trials haven’t panned out. A large new study suggests fluvoxamine might be different.

This is huge news! A common, already approved drug is showing a lot of promise for reducing Covid hospitalizations, with no more side affects than an SSRI (because it is an SSRI).

If this pans out, it could be a great stop-gap until we have a covid specific medication that doesn't need to be administered in the hospital